Company / Net Income
Fulgent Genetics, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$60.5M
FY2025
5-year range
-$60.5M / $507.4M
FY2021-FY2025
Trend
-41.7%
vs FY2024
Sector context
#119 of 164
Health Care
What the data says
At -$61M, Fulgent Genetics, Inc.'s net income ranks #119 of 164 in the Health Care sector. Net Income has fluctuated over the past 10 years, ranging from -$61M in FY2025 to $507M in FY2023.
Based on SEC 10-K filings.
-$61M in FY2025.
Declined from $507M to -$61M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#119 of 164 in Health CareTop 73% of 164This company -$60.5M Sector average $467.5M
▼
-112.9% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 41.7% year-over-year.
- Ranks #119 out of 164 companies in the Health Care sector.
- Peak net income was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$60.5M | -41.7% |
| FY2024 | -$42.7M | -108.4% |
| FY2023 | $507.4M | +136.7% |
| FY2022 | $214.3M | +52243.6% |
| FY2021 | -$411.0K | -100.2% |
| FY2020 | $214.3M | +3922.2% |
| FY2019 | -$5.6M | -123.4% |
| FY2018 | -$2.5M | +0.0% |
| FY2017 | -$2.5M | +41.4% |
| FY2016 | -$4.3M | +48.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026